STOCK TITAN
  1. Home
  2. Sec-filings
  3. UNCY
  4. [Form 4] Unicycive Therapeutics, Inc. Insider Trading Activity

Unicycive (UNCY) director Sandeep Laumas granted two new RSU awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Laumas Sandeep reported acquisition or exercise transactions in this Form 4 filing.

Unicycive Therapeutics director Sandeep Laumas received two restricted stock unit grants as equity compensation. One RSU award covers 42,100 underlying shares of common stock and will vest in three equal annual installments starting on the first anniversary of the grant date, contingent on continued service.

The second, annual RSU award covers 84,200 underlying shares of common stock and will vest in full one year after the grant date, also subject to his continued service with the company. Following these grants, his reported direct RSU holdings tied to these awards total 126,300 and 84,200 units, respectively.

Positive

  • None.

Negative

  • None.
Insider Laumas Sandeep
Role null
Type Security Shares Price Value
Grant/Award Restricted Stock Units 84,200 $0.00 --
Grant/Award Restricted Stock Units 42,100 $0.00 --
Holdings After Transaction: Restricted Stock Units — 84,200 shares (Direct, null)
Footnotes (1)
  1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer. Represents grant of restricted stock units (the "Annual RSU Award") payable solely in common stock of the Issuer. The shares subject to the Annual RSU Award shall vest one year after date of grant, subject to the Reporting Person's continued service with the Issuer.
RSU grant size 42,100 units RSU Award, granted on May 14, 2026
Annual RSU grant size 84,200 units Annual RSU Award, granted on May 14, 2026
Holdings after 42,100-unit grant 126,300 units Total RSUs under that award following grant
Holdings after 84,200-unit grant 84,200 units Total RSUs under annual award following grant
Transaction price per RSU $0.0000 Equity compensation grants, not market purchases
Restricted Stock Units financial
"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSU Award financial
"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer."
Annual RSU Award financial
"Represents grant of restricted stock units (the "Annual RSU Award") payable solely in common stock of the Issuer."
vest financial
"The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Laumas Sandeep
(Last)(First)(Middle)
C/O UNICYCIVE THERAPEUTICS, INC.
1975 W. EL CAMINO REAL SUITE 204
(Street)
MOUNTAIN VIEW CALIFORNIA 94040
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Unicycive Therapeutics, Inc. [ UNCY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$005/14/2026A84,200 (1) (1)Common Stock84,200$084,200D
Restricted Stock Units$005/14/2026A42,100 (2) (2)Common Stock42,100$0126,300D
Explanation of Responses:
1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer.
2. Represents grant of restricted stock units (the "Annual RSU Award") payable solely in common stock of the Issuer. The shares subject to the Annual RSU Award shall vest one year after date of grant, subject to the Reporting Person's continued service with the Issuer.
/s/ Sandeep Laumas05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Unicycive Therapeutics (UNCY) director Sandeep Laumas report on this Form 4?

He reported receiving two grants of restricted stock units as equity compensation. One grant covers 42,100 underlying common shares, and a separate annual grant covers 84,200 shares, both payable solely in Unicycive common stock and subject to vesting conditions tied to continued service.

How many restricted stock units did Sandeep Laumas receive from Unicycive (UNCY)?

He received 42,100 restricted stock units in one award and 84,200 restricted stock units in a separate annual award. Each RSU is payable solely in Unicycive common stock, giving him additional equity exposure subject to the vesting schedules described in the grants.

What are the vesting terms of Sandeep Laumas’s 42,100-unit RSU award from Unicycive (UNCY)?

The 42,100-unit RSU award vests in three equal installments over three years. One-third of the units vests on each anniversary of the grant date, provided Laumas continues to serve the company during the entire vesting period, aligning compensation with ongoing board service.

How does the annual 84,200-unit RSU award for Unicycive (UNCY) vest?

The annual RSU award of 84,200 units vests in a single installment one year after the grant date. Vesting is conditioned on Laumas’s continued service with Unicycive through that one-year anniversary, after which the vested units are payable in common stock.

Are the Unicycive (UNCY) RSU grants to Sandeep Laumas open-market purchases or sales?

No, they are not open-market trades. Both transactions are coded as grants or awards (code A), meaning they represent equity compensation granted by Unicycive, not shares bought or sold on the market by Laumas, and they carry no transaction price per share.

How many Unicycive (UNCY) restricted stock units does Laumas hold after these grants?

After the 42,100-unit grant, his holdings under that RSU award total 126,300 units. Separately, following the 84,200-unit annual grant, his holdings under that new award are 84,200 units, reflecting two distinct RSU positions with different vesting schedules and conditions.